Clinical Trials Browser

INDUSTRY × 3rd Line GIST × Imatinib Mesylate × Clear all

NCT01468688 2020-12-21

A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

Phase 1 Completed

3rd Line GIST